Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Metsera, Inc.

Metsera, Inc. (MTSR) Stock Overview

Explore Metsera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MTSR●NASDAQ
HealthcareBiotechnology
$70.50
$0.25(0.35%)
U.S. Market is Open · 14:09

Metsera, Inc. (MTSR)

Meyka AI Score

Z

Key Financials

Market Cap7.4B
P/E Ratio-28.09
EPS (TTM)$-2.99
ROE-0.61%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$148.30

MTSR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Metsera, Inc. (NASDAQ: MTSR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Metsera, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MTSR on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $148.30 for the NASDAQ listing.

Key metrics behind Metsera, Inc.'s NASDAQ-traded stock include a P/E ratio of -28.09 and a market capitalization of 7.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MTSR on the NASDAQ.

Price Performance (NASDAQ: MTSR)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
97.65%
6-Month Change
139.96%
Year-to-Date (YTD) Change
166.04%
1-Year Change
166.04%
3-Year Change
166.04%
5-Year Change
166.04%
All-Time (Max) Change
166.04%

Contact Information

https://www.pfizer.com
212 784 6595
3 World Trade Center, New York City, NY, 10007

Company Facts

930 Employees
IPO DateJan 31, 2025
CountryUS

Frequently Asked Questions